Literature DB >> 2996161

The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.

A E Yellin, P N Heseltine, T V Berne, M D Appleman, M A Gill, C E Riggio, F C Chenella.   

Abstract

A prospective, randomized, double-blinded comparison of Sulbactam and ampicillin and clindamycin and gentamicin is described. The combination of ampicillin and Sulbactam was not as effective in the management of perforated appendicitis and gangrenous appendicitis as was clindamycin and gentamicin. While both combinations of antibiotics had good anaerobic activity and failures were not associated with the recovery of Bacteroides fragilis group organisms, infectious complications were seen in patients from whom Pseudomonas were isolated. These pseudomonads were not nosocomially acquired and were found especially in patients with perforated appendicitis. We concluded that the combination of clindamycin and gentamicin, although less convenient to administer to the patient, remains the adjunctive antibiotic management of choice for perforated or gangrenous appendicitis. The epidemiologic factors of Pseudomonas species as a primary pathogen in peritonitis deserves further attention.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996161

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  22 in total

Review 1.  [Antimicrobial and antimycotic therapy of intra-abdominal infections].

Authors:  P Kujath; M Hoffmann; A Rodloff
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

Review 2.  Current antimicrobial therapy of anaerobic infections.

Authors:  C V Sanders; K E Aldridge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

3.  Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

Authors:  M E Falagas; L Barefoot; J Griffith; R Ruthazar; D R Snydman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

4.  Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.

Authors:  Stephen P Hawser; Samuel K Bouchillon; Christine Lascols; Meredith Hackel; Daryl J Hoban; Robert E Badal; Neil Woodford; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

5.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.

Authors:  T V Berne; A E Yellin; M D Appleman; M A Gill; F C Chenella; P N Heseltine
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

7.  Adjunctive antimicrobial therapy for complicated appendicitis: bacterial overkill by combination therapy.

Authors:  J A Hopkins; S E Wilson; D G Bobey
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

Review 8.  Piperacillin/tazobactam in the treatment of polymicrobial infections.

Authors:  S L Gorbach
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 9.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

10.  Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.

Authors:  A P Walker; R L Nichols; R F Wilson; B A Bivens; D D Trunkey; C E Edmiston; J W Smith; R E Condon
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.